Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – Time to Sell?

Merck KGaA (OTCMKTS:MKGAF) gapped down prior to trading on Tuesday . The stock had previously closed at $157.36, but opened at $148.4920. Merck KGaA shares last traded at $155.17, with a volume of 1,810 shares changing hands.

Merck KGaA Stock Performance

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $19.07 billion, a price-to-earnings ratio of 22.52 and a beta of 0.96. The stock’s fifty day moving average is $162.16 and its two-hundred day moving average is $149.60.

Institutional Trading of Merck KGaA

A number of institutional investors have recently bought and sold shares of MKGAF. MASTERINVEST Kapitalanlage GmbH bought a new stake in Merck KGaA during the second quarter worth about $4,896,000. Puzo Michael J bought a new stake in Merck KGaA in the second quarter worth approximately $2,230,000. Somerville Kurt F bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $1,997,000. Pinnacle Holdings LLC purchased a new stake in shares of Merck KGaA in the second quarter worth approximately $1,487,000. Finally, North Star Asset Management Inc. purchased a new position in Merck KGaA during the second quarter worth about $1,411,000. Institutional investors own 0.10% of the company’s stock.

Merck KGaA Company Profile

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The business serves customers in more than 60 countries through three operating sectors: Healthcare, Life Science and Electronics.

The Healthcare sector develops and markets prescription medicines and specialty therapies, with activities focused on areas including oncology, neurology and immunology, fertility, and endocrinology.